On August 10, 2018, the U.S. Centers for Disease Control and Prevention (CDC) reported an increase in babies born to opioid addicted mothers (also known as mothers with opioid use disorder). Hospital discharge data show [...]
The FDA has restricted sales of Essure birth control devices, according to the New York Times and other news sources. Sales of the contraceptive implant will now be limited to medical providers who agree to [...]
Hospital losses from increasing medical negligence claims are among the opioid epidemic’s hidden costs. The opioid crisis has overtaxed hospitals throughout Pennsylvania and across the country, increasing the potential for malpractice claims against hospital physicians, [...]
The Allegheny County Coroner’s Office records Allegheny County’s opioid overdose deaths on County death certificates. In 98% of Allegheny County overdose deaths, the specific drugs involved in a fatal overdose are listed on the decedent’s [...]
On January 23, 2018, City of Philadelphia officials decided to move forward with plans to establish Philadelphia Opioid Safe Injection Sites. Safe injection sites for users of heroin, fentanyl-laced drugs, and other street opioids are [...]
The Allegheny County, PA Coroner’s Office reports that official Allegheny Country 2017 drug deaths exceeded those in 2016. The County’s drug deaths from 2016 also exceeded those in 2015, which exceeded those in 2014, an [...]
On December 5, 2017, the Judicial Panel on Multidistrict Litigation (JPML) formed an Opioid MDL, sending 180+ federal opioid cases to the Northern District of Ohio. The transferred cases were brought by governmental entities, such [...]
Our country is in the clutches of a burgeoning opioid epidemic, and Allegheny County’s opioid crisis is exceptionally dire. Overdose deaths in Allegheny County are significantly higher than the national rate. In 2015, when the [...]
On Tuesday, December 5, 2017, a Philadelphia jury awarded plaintiff Lynn Hartman nearly $28 million after finding that drug makers Johnson & Johnson and Bayer AG had provided inadequate warnings of the bleeding dangers associated [...]
In closing arguments made December 1, 2017, counsel for plaintiff urged a jury to find that inadequate Xarelto warnings left the plaintiff with serious internal bleeding. Plaintiffs have argued that Janssen Pharmaceuticals and Bayer Healthcare [...]
For more than two decades, attorney Rosemary Pinto has fought for the rights of plaintiffs injured by dangerous pharmaceuticals. The Feldman & Pinto co-founder has recently expanded her fight to include the opioid epidemic, a [...]
In August 2017, Feldman & Pinto’s personal injury and wrongful death lawyers achieved a settlement for plaintiffs in a deadly tree falling case. The claims arose from a tragic incident on June 30, 2012, at [...]
Testimony by former FDA commissioner David Kessler favored the plaintiff in a Philadelphia state court Xarelto trial that commenced November 6, 2017. On November 14, Kessler opined that the warning labels for the blood thinner [...]
Feldman & Pinto’s personal injury lawyers co-represent plaintiffs in a Xarelto mass tort trial that commenced in Philadelphia state court on November 6, 2017. Xarelto is a dangerous anticoagulant (blood thinner), manufactured by Bayer and marketed [...]
NOTE: Feldman & Pinto no longer handles cases related to injuries caused by Watchman devices. Studies conducted before and after FDA approval of Boston Scientific's anti-stroke device show that Watchman stroke devices can cause serious [...]
Research conducted in 2016 has revealed possible causes of IVC Filter breakage. Surgeons insert IVC Filters (small metal medical devices) in a vein called the inferior vena cava to prevent pulmonary embolisms (life-threatening blood clots [...]
Ethicon / Johnson & Johnson issued an urgent field safety notice in 2016, advising of a worldwide recall of its Ethicon Physiomesh™ Flexible Composite Mesh. Ethicon Physiomesh™ Flexible Composite Mesh is a medical device employed [...]
On November 7, 2016, Johnson & Johnson (J&J), the maker of the diabetes drug, Invokana, lost a motion to have an Invokana lawsuit moved from Pennsylvania state court to another jurisdiction. A number of Invokana [...]